✦ LIBER ✦

Why Adjuvant Trastuzumab Led to Better Outcomes in Women with High-Risk HER-2-Positive Breast Cancer

✍ Scribed by Kadri Altundag; Mauricio Z. Baptista

Book ID: 110760748
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 157 KB
Volume: 12
Category: Article
ISSN: 1075-122X
DOI: 10.1111/j.1075-122x.2006.00314.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant trastuzumab with chemotherapy i

Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer

✍ Heather L. McArthur; Kathleen M. Mahoney; Patrick G. Morris; Sujata Patil; Linds 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB 👁 1 views

## Abstract ## BACKGROUND: Several large, randomized trials established the benefits of adjuvant trastuzumab with chemotherapy. However, the benefit for women with small, node‐negative HER2‐positive (HER2+) disease is unknown, as these patients were largely excluded from these trials. Therefore, a

High recurrence risk and use of adjuvant

High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancers

✍ Akiyo Horio; Takashi Fujita; Hironori Hayashi; Masaya Hattori; Naoto Kondou; Mai 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 505 KB

Effect of adjuvant/neoadjuvant trastuzum

Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancer

✍ Murthy, Rashmi K.; Varma, Ankur; Mishra, Priyankana; Hess, Kenneth R.; Young, El 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

Management and Outcome of HER2-Positive

Management and Outcome of HER2-Positive Early Breast Cancer Treated With or Without Trastuzumab in the Adjuvant Trastuzumab Era

✍ Carlo Palmieri; Deep Shah; Jonathan Krell; Ondrej Gojis; Katy Hogben; Pippa Ridd 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 432 KB

Non-initiation and early discontinuation

Non-initiation and early discontinuation of adjuvant trastuzumab in women with localized HER2-positive breast cancer

✍ Neugut, Alfred I.; Hillyer, Grace Clarke; Kushi, Lawrence H.; Lamerato, Lois; Le 📂 Article 📅 2014 🏛 Springer Japan 🌐 English ⚖ 224 KB

Clinical outcome in women with HER2-posi

Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy

✍ Rossi, Valentina; Nolè, Franco; Redana, Stefania; Adamoli, Laura; Martinello, Ro 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 479 KB